Literature DB >> 22445027

Polymorphisms of POR, SULT2A1 and HSD11B1 in children with premature adrenarche.

Pauliina Utriainen1, Saila Laakso, Jarmo Jääskeläinen, Raimo Voutilainen.   

Abstract

Premature adrenarche (PA) refers to an earlier than normal increase in adrenocortical androgen production. The pathogenesis of PA remains largely unknown. We hypothesized that common polymorphisms at P450 oxidoreductase (POR), steroid sulfotransferase (SULT2A1), or 11β-hydroxysteroid dehydrogenase type 1 (HSD11B1) genes could contribute to the polygenic pathogenesis of PA. We performed a case-control study on the polymorphisms rs1057868 at POR, rs182420 at SULT2A1, and rs12086634 at HSD11B1. The study cohort comprised 73 prepubertal children with PA (defined by clinical signs) and 97 age- and gender-matched healthy controls from a Finnish Caucasian population. Genotype distributions and clinical and metabolic phenotypes were determined. The genotype distributions of the polymorphisms were similar between the study groups. No variant was associated with alterations in serum adrenal steroid concentrations. The minor C variant at SULT2A1 was associated with higher serum sex hormone binding globulin (SHBG) concentrations (T/T, n=64 vs T/C&amp;C/C, n=33; mean 94 vs 116 nmol/L; P=.001) and a trend for lower dehydroepiandrosterone sulfate/dehydroepiandrosterone ratios in the controls (P=.06), and with higher plasma total cholesterol concentrations in the PA subjects (T/T, n=42 vs T/C&amp;C/C, n=31; 4.0 vs 4.6 mmol/L; P<.001). The minor G variant at HSD11B1 was associated with lower plasma triglyceride concentration in the controls (T/T, n=65 vs T/G&amp;G/G, n=32; 0.61 vs 0.49 mmol/L; P=.013). Common polymorphisms at POR, SULT2A1 or HSD11B1 were not associated with PA in a Finnish Caucasian population.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22445027     DOI: 10.1016/j.metabol.2012.02.008

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

Review 1.  Pharmacogenomics of human P450 oxidoreductase.

Authors:  Amit V Pandey; Patrick Sproll
Journal:  Front Pharmacol       Date:  2014-05-09       Impact factor: 5.810

2.  A SULT2A1 genetic variant identified by GWAS as associated with low serum DHEAS does not impact on the actual DHEA/DHEAS ratio.

Authors:  Robin Haring; Henri Wallaschofski; Alexander Teumer; Heyo Kroemer; Angela E Taylor; Cedric H L Shackleton; Matthias Nauck; Uwe Völker; Georg Homuth; Wiebke Arlt
Journal:  J Mol Endocrinol       Date:  2012-12-31       Impact factor: 5.098

3.  Gender-dependent association of HSD11B1 single nucleotide polymorphisms with glucose and HDL-C levels.

Authors:  Luciane Viater Turek; Neiva Leite; Ricardo Lehtonen Rodrigues Souza; Jovana Karoline Lima; Gerusa Eisfeld Milano; Luciana da Silva Timossi; Ana Claudia Vecchi Osiecki; Raul Osiecki; Lupe Furtado Alle
Journal:  Genet Mol Biol       Date:  2014-09       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.